| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | WATERS CORPORATION COMMON ST | Apr 30, 2026 | |
| Sell | West Pharmaceutical Services | Jul 22, 2025 | |
| Buy | West Pharmaceutical Services | Jun 17, 2025 | |
| Sell | WEST PHARMACEUTICAL SERVICES | May 19, 2025 | |
| Sell | West Pharmaceutical Services | Apr 8, 2025 | |
| Buy | West Pharmaceutical Services | Feb 25, 2025 | |
| Sell | West Pharmaceutical Services | Feb 13, 2025 | |
| Buy | WEST PHARMACEUTICAL SERVICES | Feb 9, 2025 | |
| Buy | West Corp. Common Stock | Jan 6, 2025 | |
| Sell | West Pharmaceutical Services | Nov 8, 2024 |
This page tracks congressional stock trading activity in West Pharmaceutical Services, Inc. (WST) in the Healthcare sector. Disclosed Capitol has indexed 65 disclosed congressional trades involving WST. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of May 2026 — Disclosed Capitol has tracked 65 disclosed congressional trades in West Pharmaceutical Services, Inc. (WST) — 29:27 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Apr 30, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Jul 22, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Jun 17, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
| May 19, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Apr 8, 2025 | Rob Bresnahan | R | Sale | $1,001 - $15,000 |
| Feb 25, 2025 | Rob Bresnahan | R | Buy | $1,001 - $15,000 |
| Feb 13, 2025 | Jared Moskowitz | D | Sale | $1,001 - $15,000 |
| Feb 9, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Jan 6, 2025 | Nancy Pelosi | D | Purchase | $100,001 - $250,000 |
| Nov 8, 2024 | Jared Moskowitz | D | Sale | $1,001 - $15,000 |
Across the 65 disclosed congressional trades in West Pharmaceutical Services, Inc. (WST), members of Congress have reported 27 buys and 29 sells. The average 30-day alpha vs. the S&P 500 is 0.70%.
As of June 2026, West Pharmaceutical Services, Inc. has 145 federal contract award records on file from USAspending.gov — most recently $1.3M from the Department of State on 2026-06-02.
| Award date | Agency | Amount |
|---|---|---|
| 2026-06-02 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $1.3M |
| 2026-05-27 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $702K |
| 2026-05-20 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $5.6M |
| 2026-04-30 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $2.1M |
| 2026-04-10 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $4.0M |
| 2026-04-10 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $1.5M |
| 2026-04-10 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $589K |
| 2026-04-01 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $5.6M |
| 2026-03-31 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $5.6M |
| 2026-02-10 | Department of State · International Boundary and Water Commission: U.S.-Mexico | $8.7M |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, West Pharmaceutical Services, Inc. reported revenue of $3.07B and net income of $493.7M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $1.72B, net income $292.8M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.